These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15824035)

  • 1. Systematic delivery of chloroquine and promethazine using pH-sensitive polymers.
    Attama AA; Ezeamama UF
    Drug Deliv; 2005; 12(2):103-7. PubMed ID: 15824035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
    Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
    J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic drug--enterosoluble polymer coevaporates: development of oral controlled release systems.
    Govindarajan R; Nagarsenker MS
    Drug Dev Ind Pharm; 2004 Sep; 30(8):847-57. PubMed ID: 15521330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP.
    Dashevsky A; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
    Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
    Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention and transit of intestinal mucoadhesive films in rat small intestine.
    Eaimtrakarn S; Itoh Y; Kishimoto JI; Yoshikawa Y; Shibata N; Takada K
    Int J Pharm; 2001 Aug; 224(1-2):61-7. PubMed ID: 11472815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained ophthalmic delivery of highly soluble drug using pH-triggered inner layer-embedded contact lens.
    Zhu Q; Cheng H; Huo Y; Mao S
    Int J Pharm; 2018 Jun; 544(1):100-111. PubMed ID: 29627356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets.
    Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R
    Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melt-Extruded Eudragit® FS-Based Granules for Colonic Drug Delivery.
    Zhang F
    AAPS PharmSciTech; 2016 Feb; 17(1):56-67. PubMed ID: 26162974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)-mesalamine complexes.
    Quinteros DA; Manzo RH; Allemandi DA
    Drug Deliv; 2010 May; 17(4):208-13. PubMed ID: 20230248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoxyethylene-poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral delivery.
    Carelli V; Di Colo G; Nannipieri E; Poli B; Serafini MF
    Int J Pharm; 2000 Jul; 202(1-2):103-12. PubMed ID: 10915932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple and rapid method for the quantification of Eudragit RS100 and RL100 poly(methacrylates) in sustained-release dosage forms.
    Melia CD; Hansraj BR; Khan KA; Wilding IR
    Pharm Res; 1991 Jul; 8(7):899-902. PubMed ID: 1924142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial Nanofibrous Mats Composed of Eudragit for pH-Dependent Dissolution.
    Son YJ; Kim Y; Kim WJ; Jeong SY; Yoo HS
    J Pharm Sci; 2015 Aug; 104(8):2611-8. PubMed ID: 26053132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.